Kisspeptin


Overview

Kisspeptin is a neuropeptide that sits at the very top of the reproductive hormone cascade. Discovered in 1996 (and named after Hershey Kisses, where the gene was identified), it turned out to be the master switch of puberty and fertility — the signal that tells the hypothalamus to release GnRH.

It has genuine human research behind it, mostly in fertility medicine and reproductive endocrinology.

How It Works

Kisspeptin neurons in the hypothalamus integrate metabolic, stress and seasonal signals and translate them into GnRH pulses. GnRH then drives LH and FSH release from the pituitary, which drive testosterone, estrogen and gamete production.

Why it matters

Because kisspeptin acts upstream of everything, it can restart a suppressed reproductive axis — human studies show it triggering LH pulsatility in people with hypothalamic amenorrhea and low-testosterone states. This made it interesting to the TRT and post-cycle therapy communities.

Key Benefits

Reproductive axis activation — documented LH/FSH stimulation in human studies.

Fertility research — used clinically to trigger egg maturation in IVF, with a better safety profile than hCG for ovarian hyperstimulation risk.

Mood and sexual behavior — brain imaging studies show effects on limbic processing of sexual and emotional stimuli.

PCT interest — theoretical tool for restarting suppressed testosterone production.

Side Effects & Considerations

Human studies report good tolerability with occasional flushing and transient hormonal effects. The peptide world interest in kisspeptin for post-cycle recovery is mechanistically sound but clinically unvalidated — no trials exist for that use.

Realistic view

For fertility medicine, kisspeptin is a promising, legitimately researched tool. For grey-market hormonal optimization, it is an elegant theory awaiting evidence — and the established alternatives (hCG, SERMs) have decades of clinical practice behind them. Not approved for general use; research continues.

Dosage protocols

Protocol Dosage Frequency Duration Notes
Research reference Varies widely in studies (mcg-range, IV or SC) Study-dependent Study-dependent No established community dosing; human use has been in clinical research settings.

Warnings

Human data exists only in research settings. Not approved for general use. Established PCT options have far more clinical support.